Sequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinoma: NEOPA- a randomized multicenter phase III study (NCT01900327, DRKS00003893, ISRCTN82191749)

BACKGROUND: Median OS after surgery in curative intent for non-metastasized pancreas cancer ranges under study conditions from 17.9 months to 23.6 months. Tumor recurrence occurs locally, at distant sites (liver, peritoneum, lungs), or both. Observational and autopsy series report local recurrence r...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Tachezy, Michael, Gebauer, Florian, Petersen, Cordula, Arnold, Dirk, Trepel, Martin, Wegscheider, Karl, Schafhausen, Phillipe, Bockhorn, Maximilian, Izbicki, Jakob Robert, Yekebas, Emre
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2014
Témata:
Study Protocol
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4057592/
https://ncbi.nlm.nih.gov/pubmed/24906700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-411
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky